[go: up one dir, main page]

ES8502869A1 - Use of a substance obtained from blood serum for the stabilization of prostaglandins. - Google Patents

Use of a substance obtained from blood serum for the stabilization of prostaglandins.

Info

Publication number
ES8502869A1
ES8502869A1 ES500225A ES500225A ES8502869A1 ES 8502869 A1 ES8502869 A1 ES 8502869A1 ES 500225 A ES500225 A ES 500225A ES 500225 A ES500225 A ES 500225A ES 8502869 A1 ES8502869 A1 ES 8502869A1
Authority
ES
Spain
Prior art keywords
blood serum
prostaglandins
stabilizing
stabilization
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES500225A
Other languages
Spanish (es)
Other versions
ES500225A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8502869A1 publication Critical patent/ES8502869A1/en
Publication of ES500225A0 publication Critical patent/ES500225A0/en
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

What are disclosed are: a substance, obtained from blood serum and having a molecular weight below 2000, which is suitable for stabilizing prostaglandins, especially those of the A, E, F, or I type methods for preparing such a stabilizing substance from blood serum pharmaceutical preparations containing a prostaglandin or prostaglandin derivative together with such a stabilizing substance and methods for stabilizing a pharmaceutical preparation containing a prostaglandin or prostaglandin derivative.
ES500225A 1980-03-15 1981-03-10 PROCEDURE FOR THE STABILIZATION OF PHARMACEUTICAL PREPARATIONS FOR PROSTAGLANDINAS. Granted ES500225A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803010002 DE3010002A1 (en) 1980-03-15 1980-03-15 PROSTAGLANDINE CONTAINING PHARMACEUTICAL PREPARATION

Publications (2)

Publication Number Publication Date
ES8502869A1 true ES8502869A1 (en) 1985-02-01
ES500225A0 ES500225A0 (en) 1985-02-01

Family

ID=6097308

Family Applications (2)

Application Number Title Priority Date Filing Date
ES500225A Granted ES500225A0 (en) 1980-03-15 1981-03-10 PROCEDURE FOR THE STABILIZATION OF PHARMACEUTICAL PREPARATIONS FOR PROSTAGLANDINAS.
ES510484A Expired ES8303324A1 (en) 1980-03-15 1982-03-16 Use of a substance obtained from blood serum for the stabilization of prostaglandins.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES510484A Expired ES8303324A1 (en) 1980-03-15 1982-03-16 Use of a substance obtained from blood serum for the stabilization of prostaglandins.

Country Status (9)

Country Link
US (1) US4333948A (en)
EP (1) EP0036514B1 (en)
JP (1) JPS56150018A (en)
AT (1) ATE16809T1 (en)
AU (1) AU545065B2 (en)
CA (1) CA1164343A (en)
DE (2) DE3010002A1 (en)
ES (2) ES500225A0 (en)
ZA (1) ZA811672B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2536019T3 (en) 2011-06-17 2018-06-29 Diehl Ako Stiftung & Co. Kg Method for controlling an inverter
CN102832880B (en) 2011-06-17 2017-03-01 迪尔阿扣基金两合公司 The method controlling transducer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617510A1 (en) * 1966-04-20 1971-03-11 Wolfgang Dr Med Helmbold Process for the extraction of growth and metabolism promoting low molecular weight substances
FR1535488A (en) * 1966-04-20 1968-08-09 Behringwerke Ag Low molecular weight substance and its isolation from blood fractions
US4113882A (en) * 1974-10-21 1978-09-12 Yamanouchi Pharmaceutical Co., Ltd. Stabilized oral prostaglandin formulation and the process for the preparation thereof
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
GB2021581B (en) * 1978-05-17 1982-10-20 Wellcome Found Stabilisation of pgl derivatives
US4178454A (en) * 1978-10-11 1979-12-11 Toray Industries, Inc. Stabilized prostaglandin E composition

Also Published As

Publication number Publication date
DE3173084D1 (en) 1986-01-16
EP0036514A2 (en) 1981-09-30
ES510484A0 (en) 1983-02-01
CA1164343A (en) 1984-03-27
ES8303324A1 (en) 1983-02-01
DE3010002A1 (en) 1981-10-01
EP0036514B1 (en) 1985-12-04
ZA811672B (en) 1982-03-31
AU545065B2 (en) 1985-06-27
AU6835881A (en) 1981-09-24
US4333948A (en) 1982-06-08
ATE16809T1 (en) 1985-12-15
ES500225A0 (en) 1985-02-01
JPS56150018A (en) 1981-11-20
EP0036514A3 (en) 1982-06-09

Similar Documents

Publication Publication Date Title
NO170126C (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS IN THE FORM OF SUSPENSIONS CONTAINING SUCRALPHAT
ATE22562T1 (en) 6-SUBSTITUTE S-TRIAZOLO(3,4-A)PHTHALAZINE DERIVATIVES.
NO854194L (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING ANTRACYCLING GYCOSIDES.
NO870560D0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
FI812810A7 (en) Ammoniomethyl compounds, methods for their preparation, pharmaceutical preparations containing these compounds and the use of the latter.
EP0014958A3 (en) Process for the preparation of 4,5-perfluoro-1,3-dioxolanes
ES8305684A1 (en) Aminopropanol derivatives of 2-hydroxy-beta-phenyl propiophenones, processes for their preparation and therapeutic agents containing them.
DE3261832D1 (en) Method for the stabilisation of peroxidase in a liquid medium, and the stabilised medium so obtained
ES8705763A1 (en) Pharmaceutical compositions containing gels.
DE2966046D1 (en) Pharmaceutical formulations containing prostaglandin compounds and method for their preparation
ES8502869A1 (en) Use of a substance obtained from blood serum for the stabilization of prostaglandins.
AU597090B2 (en) 2-acyloxypropylamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IT7927962A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 7-AMINO-DESACETOXYCEPHALOSPORANIC ACID.
BG90414A (en) 2-AZABICYCLO (2,2,1)-HEPT-5-EN-2-ACETIC ACID AND ITS DERIVATIVES, METHOD OF PREPARATION AND THEIR APPLICATION
DE3161204D1 (en) 2-alkyl-5-hydroxy-1,4-naphthoquinones, process for their manufacture and pharmaceutical preparations containing these compounds
NO920791D0 (en) MIXTURE FOR STABILIZATION OF BLOOD PLASMA DURING PASTEURIZATION
NO842514L (en) PROCEDURE FOR THE PREPARATION OF BICYCLO (3,2,1) OCTANCARBOXYLIC ACID DERIVATIVES.
NO822801L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2.5 DISUBSTITUTED FURANTS
NL7901103A (en) 1,1-SUBSTITUTED OCTAHYDROINDOLE 2,3-A CHINOLI PHRASES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; PROCESS FOR THE PREPARATION OF THESE COMPOUNDS, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, WITH VASE-REMOVING PROPERTIES.
GB2021581A (en) Stabilisation of PGl2 derivatives
AU5246879A (en) Preparation of cyclo-1,3,2-oxazaphosphoryl derivatives
IT8223501A0 (en) DERIVATIVES OF 1,2,3-THIADIAZOL-5-IL-UREA, PROCEDURES FOR THE PREPARATION OF THESE COMPOUNDS AS WELL AS MEANS CONTAINED WITH GROWTH REGULATING AND DEFOLIATING EFFECT.
IT8026451A0 (en) PROCEDURE FOR THE PREPARATION OF AZANIDAZOLE.
ES8500006A1 (en) Insecticide formulations.
GB1410554A (en) Thioadenosines